/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */ <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7KNSFJ" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Please remember that these discussion boards are a public forum, which means open to the public (i.e. non-CSN members) and the content can be found via internet search engines. Members are strongly advised not to share personal identifiers such as real names, email address, telephone number, street address, etc. This information can be used to identify you and link you to the content you provide. Other areas of CSN are restricted to members only and cannot be found by search engines.

Multiple Myeloma

Archives for August 2010

immpower
Does anyone have information about immpower. Are there studies being conducted on how effective it may be on treating multiple myeloma?
complex karyotype
Diagnosed with MM May 2010. Completed 4 cycles of Dex/Velcade/Revlamid and feel really very good. Neurapthy has gone away. I am scheduled for SCT at Emory in Atlanta in about 3 weeks. The catheter goes in next week. My Doc seems unwilling to give any precise prognosis. Has anyone out there with high risk mm completed a SCT…

/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2023 © Cancer Survivors Network